Experian (BSP:EXPB31) Research & Development: R$0 Mil (TTM As of Mar. 2026)


BSP:EXPB31 Experian PLC BSP:EXPB31
82 GF Score
Price R$239.00
GF Value R$374.24
! 1 Warning Sign
View Full Analysis

What is Experian Research & Development?

Experian BSP:EXPB31 82 Research & Development is R$0 Mil as of Mar. 2026. GuruFocus rates BSP:EXPB31 with a GF Score™ of 82/100 and a GF Value™ of R$374.24. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Experian's Research & Development for the six months ended in Mar. 2026 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was R$0 Mil.

Experian  (BSP:EXPB31) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Experian Research & Development Related Terms

Experian Research & Development Historical Data

* Premium members only.

The historical data trend for Experian's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Experian Research & Development Chart

Experian Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Experian Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BSP:EXPB31
82GF Score
Experian PLC BSP:EXPB31
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Experian Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R$0 Mil mean?
Experian (BSP:EXPB31) has a Research & Development of R$0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Experian and its competitors.
Is Experian's Research & Development too high?
Experian's current Research & Development is R$0 Mil. Overall, Experian has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Experian's Research & Development compare to VRSK and EFX?
Experian's Research & Development of R$0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Experian and its competitors. Experian's current Research & Development is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Experian stock overvalued right now?
Experian (BSP:EXPB31) has a current Research & Development of R$0 Mil. The stock's GF Value™ is R$374.24, compared to a current price of R$239.00 — trading 36.1% below its estimated fair value. The current Research & Development is R$0 Mil. Experian's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Experian (BSP:EXPB31), the current Research & Development is R$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Experian (BSP:EXPB31) Overvalued in 2026?

Based on GuruFocus' analysis, Experian stock appears to be undervalued. The current stock price of R$239.00 is trading 36.1% below its estimated GF Value™ of R$374.24.

Key valuation signals for BSP:EXPB31:

  • Research & Development: R$0 Mil
  • GF Value™: R$374.24 vs. price of R$239.00 (36.1% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the BSP:EXPB31 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Experian Business Description

Address Fenian Street, 2 Cumberland Place, Dublin 2, IRL, D02 HY05
Experian is one of the leading credit bureaus in North America and the United Kingdom, providing the consumer information that is the basis for making lending decisions. The company also provides decision analytics, marketing data, and direct-to-consumer credit products and services. Roughly one quarter of the company's revenue is generated outside of North America and the United Kingdom, primarily in Latin America and Asia.
82GF Score

Get the complete analysis for BSP:EXPB31

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$239.00
Price
R$374.24
GF Value